Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LSL Pharma Group Inc V.LSL

Alternate Symbol(s):  LPGIF

Consumer Defensive Household & Personal Products
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.

Recent & Breaking News (TSXV:LSL)

    LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units

    GlobeNewswire 2 days ago

    LSL Pharma Group Announces the Addition of New Members to Its Board of Directors

    GlobeNewswire 3 days ago

    LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million

    GlobeNewswire April 11, 2024

    LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "

    GlobeNewswire April 9, 2024

    LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements

    GlobeNewswire March 19, 2024

    LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million

    GlobeNewswire March 7, 2024

    LSL Pharma Group Announces an Extension of its Convertible Debentures Offering

    GlobeNewswire January 8, 2024

    LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

    GlobeNewswire December 8, 2023

    LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

    GlobeNewswire December 4, 2023

    LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023

    GlobeNewswire November 29, 2023

    LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

    GlobeNewswire November 1, 2023

    Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million

    GlobeNewswire October 25, 2023

    LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

    GlobeNewswire October 18, 2023

    LSL Pharma Group Engages Paradox as Investor Relations Services Provider

    GlobeNewswire October 6, 2023

    LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

    GlobeNewswire September 21, 2023

    LSLPharma Group Announces Its Second Quarter Results

    GlobeNewswire August 29, 2023

    Groupe LSL Pharma Update on Increased Production Capacity and Anticipated Sales Growth

    GlobeNewswire June 20, 2023

    LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover

    GlobeNewswire March 14, 2023